|Bid||41.67 x 1100|
|Ask||41.58 x 900|
|Day's Range||40.60 - 42.04|
|52 Week Range||31.77 - 59.80|
|Beta (3Y Monthly)||1.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 4, 2019 - Nov 8, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||48.29|
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
Avanos Medical releases a study that demonstrates clinical effectiveness of COOLIEF* Cooled RF in treating chronic knee pain and providing long-term pain relief. ALPHARETTA, Ga. , Sept. 26, 2019 /PRNewswire/ ...
- BioQ Announces agreement with Avanos to Commercialize Ready-to-Use Infusion Products in North America SAN FRANCISCO , Sept. 17, 2019 /PRNewswire/ -- BioQ Pharma Incorporated, a specialty pharmaceutical ...
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical, Inc. (NYSE:AVNS), which is in the medical equipment business, and is based in United States, received...
ALPHARETTA, Ga. , Aug. 29, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody , chief executive officer, will present at the Morgan Stanley Global Healthcare Conference ...
Avanos Medical (AVNS) delivered earnings and revenue surprises of 12.00% and -0.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
ALPHARETTA, Ga. , Aug. 6, 2019 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2019 results and revised its full-year 2019 outlook. "I'm pleased we delivered sales ...
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALPHARETTA, Ga., July 23, 2019 /PRNewswire/ -- Avanos Medical, Inc. (AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2019 on Tuesday, Aug. 6 at 9 a.m. ET. The conference call will be hosted by Joe Woody, chief executive officer. To join the live conference call, dial 877-240-5772 in the United States.
Anyone researching Avanos Medical, Inc. (NYSE:AVNS) might want to consider the historical volatility of the share...
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities over the years (that's why their assets under management continue to swell). We believe hedge fund sentiment should serve as a crucial tool of an […]
Avanos Medical Inc NYSE:AVNSView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for AVNS with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding AVNS totaled $73 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Designation recognizes products that bring improvements to the health care industry ALPHARETTA, Ga. , May 28, 2019 /PRNewswire/ -- Avanos Medical (NYSE: AVNS), a company focused on delivering clinically ...